Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1121-1130 of 2859 for cancer

Edit search filters
  1. A Clinical And Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma

  2. A Study Of STX-0712 In Patients With Advanced Hematologic Malignancies

    Rochester, MN

  3. A Study Of A Mindfulness-Based Intervention With A Wearable Wellness Brain Sensing Device In Newly Diagnosed Breast Cancer Patients Undergoing Surgery

    Rochester, MN

  4. A Study To Evaluate Bleomycin, Carboplatin, Etoposide, Or Cisplatin In Treating Pediatric And Adult Patients With Germ Cell Tumors

    Rochester, MN

  5. Observation Or Radiation Therapy In Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed By Surgery

    Rochester, MN

  6. A Study Evaluating The Efficacy Of Venetoclax Plus Ibrutinib In Subjects With T-cell Prolymphocytic Leukemia

    Rochester, MN

  7. Study Of Orally Administered AG-120 In Subjects With Advanced Hematologic Malignancies With An IDH1 Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  9. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

    Rochester, MN

  10. A Study Of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab In Previously Untreated Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma

    Rochester, MN

.

Mayo Clinic Footer